United States· US:0268-7130_1b93d422-93fe-496a-ba2a-f4ef1626ac40

HALIBUT

A medicinal product containing atlantic halibut, registered in United States by ALK-Abello, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHALIBUTATC—REGISTER NO.US:0268-7130_1b93d422…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ATLANTIC HALIBUT
Manufacturer
ALK-Abello, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0268713006
    5 mL in 1 VIAL (0268-7130-06)
  • ndc11
    0268-7130-06

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1d3c30f-dcf7-4fd3-80ba-cf15af0b217b
GET /v1/drugs/c1d3c30f-dcf7-4fd3-80ba-cf15af0b217b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "PERCUTANEOUS",
  "source": "ndc",
  "strength": ".1",
  "substance": "ATLANTIC HALIBUT",
  "productndc": "0268-7130",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/mL",
  "application_number": "BLA103753",
  "marketing_category": "BLA"
}

See everything about atlantic halibut.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.